Eterna Therapeutics Collabs with Factor Bioscience...
Category : Licensing/Collaboration Deal 21 October 2024Eterna Therapeutics collaborates with Factor Bioscience to speed up cell therapy development for onc...
Eterna Therapeutics collaborates with Factor Bioscience to speed up cell therapy development for onc...
Three-year Results for EYLEA HD® (aflibercept) Injection 8 mg Demonstrate Continued Durable Visi...
Merck presents positive results from phase 2b/3 trial of clesrovimab, an investigational RSV prevent...
Annovis Bio gets US FDA clearance to begin pivotal phase 3 studies of buntanetap, paving the way for...
Cullinan Therapeutics gets US FDA clearance to proceed phase 1 trial of CLN-978 in patients with mod...